Join the Pain group to help and get support from people like you.
Pain News (Page 4)
Aromatherapy With Peppermint Oil Beneficial After Heart Surgery
MONDAY, Aug. 7, 2023 – Use of aromatherapy with peppermint oil after open-heart surgery attenuates pain and improves sleep quality, according to a study published online Aug. 3 in BMJ Supportive &...
High-Dose VX-548 Reduces Acute Pain Over 48 Hours
FRIDAY, Aug. 4, 2023 – High-dose VX-548, an oral, highly selective inhibitor of the Nav1.8 voltage-gated sodium channel, reduces acute pain over 48 hours after abdominoplasty and bunionectomy,...
Researchers Explore New Nonaddictive Means of Fighting Pain
THURSDAY, Aug. 3, 2023 – New research shows that an experimental drug fine-tuned to a specific pain pathway can ease post-surgery aches, a finding that may eventually offer an alternative to highly...
Ouch! You Injured a Nail: Tips on Best Treatment
SUNDAY, July 30, 2023 – If you've ever slammed a door on your finger, you know how badly an injured nail feels, but do you know how to treat one? First, do what you can to prevent one. "To prevent a...
Initiating Patient-Controlled Epidural in OR Beneficial for Pain Control
MONDAY, July 24, 2023 – Initiating patient-controlled epidural anesthesia (PCEA) infusion in the operating room (OR) may improve pain control, according to a study presented at the annual American...
Multiple Myeloma Symptoms Are Generally Nonspecific
WEDNESDAY, July 19, 2023 – Multiple myeloma (MM) symptoms are generally nonspecific, according to a study published online June 25 in Cancers. Stella Bowcock, M.D., from the King's College Hospital...
Caldolor Now FDA Approved for Treatment of Fever & Pain in Infants
NASHVILLE, Tenn., May 15, 2023 /PRNewswire/ – Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Medwatch Alert: Voluntary Recall of Certain Family Dollar Over-the-Counter Products
July 21, 2022 – Family Dollar is initiating a voluntary retail level product recall of certain products regulated by the U.S. Food and Drug Administration (FDA) that were stored and inadvertently...
FDA Approves Seglentis (celecoxib and tramadol hydrochloride) for the Management of Acute Pain
October 18, 2021 – The U.S. Food and Drug Administration (FDA) approved Seglentis (celecoxib and tramadol hydrochloride), a proprietary product developed by Esteve Pharmaceuticals' R&D team. It is...
FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain
ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ – Athena Bioscience, LLC, a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has approved Qdolo™ (tramadol h...
FDA Approves Olinvyk (oliceridine) Injection for the Management of Severe Acute Pain
CHESTERBROOK, Pa., Aug. 10, 2020 (GLOBE NEWSWIRE) – Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...
FDA Medwatch Alert: Biota Biosciences Issues Voluntary Nationwide Recall of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables Because They Were Marketed Without FDA Approval
May 20, 2020 – Biota Biosciences is voluntarily recalling the following lots in the table below of Cannabidiol (CBD) Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables to the customer...
FDA Approves Anjeso (meloxicam injection) for the Management of Moderate to Severe Pain
MALVERN, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) – Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that the U.S. Food and Drug...
KemPharm Announces FDA Approval of sNDA for Two Additional Strengths of Apadaz (4.08 mg benzhydrocodone/325 mg APAP and 8.16 mg benzhydrocodone/325 mg APAP)
CORALVILLE, Iowa, Jan. 07, 2019 (GLOBE NEWSWIRE) – KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today...
FDA Medwatch Alert: Implanted Pumps: Safety Communication - Use Caution When Selecting Pain Medicine for Intrathecal Administration
ISSUE: The FDA is aware that patients undergoing treatment or management of pain are commonly given pain medicines in the spinal fluid (intrathecal administration) that are not FDA approved for use...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Chronic Pain, Back Pain, Fibromyalgia, Headache, Muscle Pain, Neuralgia, Neck Pain, Chronic Myofascial Pain, Nocturnal Leg Cramps, Reflex Sympathetic Dystrophy Syndrome, Breakthrough Pain
Related drug support groups
tramadol, gabapentin, ibuprofen, oxycodone, Tylenol, hydrocodone, naproxen, acetaminophen, meloxicam, view more... amitriptyline, aspirin, Percocet, hydroxyzine, Norco, pregabalin, duloxetine, diclofenac, methadone, OxyContin, Vicodin, codeine, cyclobenzaprine, Celebrex, Aleve, fentanyl, Advil, Voltaren, morphine, clonidine, Paracetamol Teva, nortriptyline, buprenorphine, Butrans, Paracetamol, Dilaudid, Motrin, cannabis, Tylenol PM, indomethacin, Toradol, Lortab, Ultram, Vistaril, acetaminophen / hydrocodone, Roxicodone, ketamine, Arthritis Pain, Atarax, ketorolac, Percocet 10/325, Nucynta, hydromorphone